Akių namai - Company finances
|
EUR
|
2019
From: 2019-07-15
To: 2020-04-01
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | - | 53,116 | 148,041 | 184,333 | 207,496 | 208,543 | 211,754 |
| Profit before tax | 0 | 11,089 | 44,593 | 47,445 | 49,074 | 29,700 | 16,886 |
| Net profit | 0 | 11,089 | 42,557 | 45,041 | 46,610 | 28,175 | 15,830 |
| Equity | 0 | -674 | 41,883 | 86,924 | 104,122 | 132,297 | 101,069 |
| Liabilities | - | - | - | 48,592 | 1,296 | 2,456 | 89 |
| Non-current assets | 0 | 21,176 | 60,538 | 45,161 | 29,069 | 16,717 | 9,466 |
| Current assets | 0 | 37,492 | 56,253 | 90,355 | 76,349 | 118,036 | 91,692 |
| Total assets | 0 | 58,668 | 116,791 | 135,516 | 105,418 | 134,753 | 101,158 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 17,252 | 16,597 | 25,305 |
| Social insurance contributions | - | - | - | - | 9,782 | 11,001 | 21,618 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | - | +178.7% | +24.5% | +12.6% | +0.5% | +1.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | 18.9% | 36.4% | 33.2% | 44.2% | 20.9% | 15.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 101.6% | 51.8% | 44.8% | 21.3% | 15.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 20.9% | 28.7% | 24.4% | 22.5% | 13.5% | 7.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 20.9% | 30.1% | 25.7% | 23.7% | 14.2% | 8.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.6 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 15,176 | 34,164 | 37,491 | 41,499 | 41,709 | 37,926 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Akių namai - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-06-20 | 2024-06-24 | 190.10 |
| 2024-06-18 | 2024-06-19 | 242.32 |
| 2024-06-04 | 2024-06-04 | 190.10 |
| 2024-05-16 | 2024-05-22 | 236.28 |
| 2024-05-03 | 2024-05-07 | 300.78 |
| 2023-07-19 | 2023-07-20 | 1729.37 |
| 2023-07-03 | 2023-07-06 | 87.19 |
| 2023-06-16 | 2023-07-02 | 28.56 |
| 2023-06-01 | 2023-06-07 | 203.36 |
| 2023-05-16 | 2023-05-31 | 144.73 |
| 2023-05-02 | 2023-05-08 | 144.73 |
| 2023-04-19 | 2023-04-28 | 144.73 |
Akių namai - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Akiu namai, UAB (company code 305211997) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated EUR 211.8K in revenue, slightly above EUR 208.5K in 2024 and EUR 207.5K in 2023, showing a broadly stable top line over the last three years. Net profit in 2025 was EUR 15.8K, down from EUR 28.2K in 2024 and EUR 46.6K in 2023, indicating a clear decline in profitability despite continued revenue growth. The net profit margin narrowed from 22.5% in 2023 to 13.5% in 2024 and 7.5% in 2025. At year-end 2025, total assets were EUR 101.2K, equity EUR 101.1K and liabilities only EUR 89, leaving an equity ratio of 99.9%. Return on equity and return on assets were both 15.7%, while asset turnover was 2.09x. Revenue per employee reached EUR 42.4K and profit per employee EUR 3.2K, reflecting moderate productivity alongside lower earnings.